Trends in autoinjectors and pre-filled syringes
The rise of specialty and biologics has meant that one of the fastest growing segments by value today are Injectables demonstrating a 5-Year CAGR of 10%. This growth of course has implications and creates pressures across various areas such as treatment capacity and supply chain.
Yasemin Karanis, Consultant, European Thought Leadership, IQVIA
Growth of Injectables and Implications
Infusion is still one of the largest segments within Injectables today and has the biggest impact on hospital capacity constraints as they are timely and require preparation and HCPs for administration. In a post-COVID environment, alternative delivery sites and taking the patient out of the hospital setting where possible has become increasingly important and again infusions and certain vials etc. that need preparation are some of the more challenging products to do this with.
Within injectables, Pre-Filled Syringes and Cartridges/Pens are some of the fastest growing segments. (Figure 1) The strong growth of Pre-Filled Syringes and Auto-Injectors as types of injectables may be attributed to the convenience these delivery systems provide in the administration process. In comparison to intravenous infusions, they are quicker to prepare and administer as well as more convenient and comfortable for patients. Fixed dose pre-filled syringes have the potential to alleviate pressures on hospitals that are increasingly struggling with infusion capacity.
Figure 1
Therapy Area Trends for Pre-Filled Syringes and Auto-Injectors
Self-Administration is trending wherever possible and it’s certainly most developed in diabetes where we see the highest share of Auto-Injectors providing significant benefits to patients with easy to use dosing mechanisms and safe handling. (Figure 2)
Oncology which is a disease area where complex biologics and injectables make up a big segment, is slower in comparison on the uptake in Pre-Filled Syringe and Auto Injector delivery mechanisms. Figure 2 shows the Pre-Filled Syringe and Autoinjector segments as a part of overall injectables in these therapy areas. Even though Oncology has the largest injectables segment, a much smaller proportion comes from Pre-Filled Syringes.
However, we are certainly seeing a movement towards PFS in Oncology. Not only as life-cycle management such as Roche’s HER2 franchise or Darzelex this year being approved in its Sub-cutaneous Pre-Filled Syringe formulation but there are also a number of assets being developed as sub-cut injections from the start. There is certainly room for growth for Pre-Filled Syringes in Oncology as their value is increasingly recognized.
Figure 2
Innovation in PFS and AI
Pre-Filled Syringes and Autoinjectors certainly provide value to Hospitals and HCPs through quicker and easier drug administration process but maybe most importantly they provide value to patients. The importance of focusing on the patient is increasingly recognised by companies and other stakeholders, something that is in the heart of Auto-injectors and innovation in this segment.
Biggest promise technologies or products that are patient centric can provide sit within adherence. Connectivity and improving patient experience through easy to use auto-injectors and devices, for example with discreet needle systems and designs, could help reduce this burden non-adherence has on the global healthcare system. Drug delivery device companies with impressive technologies are increasingly collaborating with pharmaceutical and biotech companies to optimize patient experience.
As the sector is evolving, the packaging industry will play a pivotal role in bringing value to the healthcare system and most importantly to patients. And as the industry is shifting towards specialty medicines and injectables, Pre-Filled Syringes and Auto-injectors are at the heart of the pharmaceutical industry going forward.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance